IRVINE, Calif., Sept. 6 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI),
the inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion
pulse oximetry, announced the completion of the University of Wisconsin
Hospital and Clinics' system-wide implementation of Masimo SET pulse oximetry.
UW Hospitals and Clinics performed an extensive comparison and thorough
evaluation spanning virtually every department and cited precise, continuous
SpO2 measurements under demanding conditions as the chief reason for
conversion to Masimo SET.
"We were looking for a product with accuracy in the face of difficult
monitoring conditions such as patient movement. After evaluating multiple
solutions for improving oximetry practice, we chose Masimo SET technology,"
said Christopher Green, M.D., Medical Director for the American Family
Children's Hospital at the University of Wisconsin Hospitals and Clinics.
The University of Wisconsin Hospital and Clinics is a 471-bed facility
that ranks among the finest academic medical centers in the United States.
With more than 80 outpatient clinics and seven satellite locations, it is one
of only two organizations in Wisconsin with designated Level One adult and
pediatric trauma centers and is recognized as a national leader in fields such
as cancer treatment, pediatrics, ophthalmology, surgical specialties and organ
transplantation.
By making the conversion to Masimo, the University of Wisconsin Hospital
and Clinics joins other top hospitals in the United States -- including four
of the top five -- as listed on the US News & World Report Honor Roll, which
have all adopted Masimo SET as their primary pulse oximetry platform. Masimo
SET is widely recognized as the most accurate and reliable pulse oximetry
technology in the world, clinically proven in more than 100 independent and
objective studies to provide the most trustworthy SpO2 readings even under the
most difficult clinical conditions, including patient motion and low
peripheral perfusion. These studies prove Masimo SET delivers improvements in
outcomes, safety and efficiency.
In addition to the University of Wisconsin Hospitals and Clinics'
system-wide standardization to Masimo SET pulse oximetry, the conversion also
allows UW Hospitals and Clinics' clinicians to utilize Masimo Rainbow SET
technology. Masimo Rainbow SET is an upgradable noninvasive blood constituent
monitoring platform that is capable of measuring additional blood constituents
that previously required invasive procedures. Masimo Rainbow SET's first
application is Pulse CO-Oximetry, the first and only technology platform
capable of continuously and noninvasively measuring carboxyhemoglobin/carbon
monoxide (SpCO), methemoglobin (SpMet), and Pleth Variability Index (PVI), in
addition to oxyhemoglobin (SpO2), perfusion index (PI), and pulse rate.
By quickly and accurately determining levels of SpCO and SpMet -- two
critical dyshemoglobins proven to increase morbidity and mortality in a broad
range of clinical settings -- clinicians can accurately determine their
patients' true oxygenation status. This allows for more precise and timely
diagnosis and treatment.
Pleth Variability Index (PVI) is a noninvasive measurement that quantifies
changes in the plethysmographic waveform derived from pulse oximetry, and may
provide clinicians with a noninvasive way to monitor functional hemodynamics
in their patients. Clinicians who have evaluated PVI believe this technology
will prove to be a valuable clinical tool with significant advantages over
currently available indicators of changes in functional hemodynamics that are
invasive, operator dependent, often inaccurate, and expensive.
Joe E. Kiani, Chairman and CEO of Masimo, stated, "We are proud to partner
with The University of Wisconsin Hospitals and Clinics in their efforts to
provide their patients with exceptional level of safety and care. This is
clearly an organization that is focused on patients and understands the
importance of adopting innovative technology to assist them in enhancing the
quality of the care they deliver. The opening of the new American Family
Children's Hospital, which is designed to give the best and kindest care
possible, are examples of UW Hospitals and Clinics' commitment in this area.
Their system-wide conversion to Masimo SET technology will further advance
patient safety and care throughout this fine organization."
About Masimo
Masimo develops innovative monitoring technologies that significantly
improve patient care -- helping solve "unsolvable" problems. In 1995, the
company debuted Read-Through Motion and Low Perfusion pulse oximetry, known as
SET, and with it virtually eliminated false alarms and increased pulse
oximetry's ability to detect life-threatening events. More than 100
independent and objective studies have confirmed that Masimo SET technology
allows clinicians to accurately monitor blood oxygen saturation in critical
care situations. Our Masimo SET platform has significantly addressed many of
the previous technology limitations, has substantially contributed to improved
patient outcomes and has been referred to by several industry sources as the
gold standard in pulse oximetry. In 2005, Masimo introduced Masimo Rainbow SET
Pulse CO-Oximetry, which, for the first time, noninvasively monitors the level
of carbon monoxide and methemoglobin in the blood, allowing early detection
and treatment of potentially life-threatening conditions. Founded in 1989,
Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of
Care by Taking Noninvasive Monitoring to New Sites and Applications."
Additional information about Masimo and its products may be found at
http://www.masimo.com.
Masimo, SET, Signal Extraction Technology, Radical, Radical-7, Rad57, APOD,
and Improving Outcomes and Reducing Cost of Care by Taking Noninvasive
Monitoring to New Sites and Applications are registered trademarks of Masimo
Corporation. ARM, Acoustic Respiratory Monitoring, BiFi, Rainbow, SpCO, SpMet,
PVI, SpHb and Pulse CO-Oximeter are trademarks of Masimo Corporation.
Contact:
Tom McCall
Masimo Corporation
949-297-7075
SOURCE Masimo